[A new hypouricosuric and antiphlogistic preparation, Suxibuzona].
D000284:Administration, Oral; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006073:Gout / Q000188:drug therapy*; D006801:Humans; D007659:Ketones / Q000008:administration & dosage / Q000627:therapeutic use; D007668:Kidney / Q000187:drug effects; D051379:Mice; D011720:Pyrazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D011817:Rabbits; D051381:Rats; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D013386:Succinates / Q000008:administration & dosage / Q000627:therapeutic use; D014528:Uricosuric Agents / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D007659:Ketones; D011720:Pyrazoles; D013386:Succinates; D014528:Uricosuric Agents
Un nuevo preparado hipouricemiante yantiflogístico Suxibuzona.